АҚШ абсолютті көшбасшы(ағылшын тілінде)

Sociology:

Article: USA is the absolute leader

Faculty: Engineering and Natural Sciences

Student: Nasiba Mukhitdinova

2022 y

“Suleyman Demirel University”

USA is the absolute leader

By Maria Chentsova

The volume and structure of the US pharmaceutical market in 2004-2006,review of leading therapeutic american pharmaceutical categories,generics and biotechnology markets,US presence in the Russian pharmaceutical market. At the time of writing this article, Maria Chentsova had studied America a lot. Conducted comparative studies with other states

Keywords: Usa, leader,

If you ask about America, no matter what country they live in, they will tell you at least 1 fact about America. The United States is the leader of the world economy, one of the largest countries in the world in terms of territory and population. In the country, on an area of ​​​​about 9.3 million square meters. km is home to more than 255 million people. In terms of the level of development of productive forces and the scale of their economy, they are far ahead of any of the other developed countries. The course of development of economic processes in the United States itself is one of the main generators of shifts in the economy of the whole world. Business activity in the United States serves as a "barometer" for the world economy, directly affects the movement of the cycle and changes in the economic situation in other countries, affects the structure of international economic exchange.

When I first read this article, I thought maybe America was on top with their products. But I understood that not only one factor affects the development of the state.

The extremely high capacity of the US domestic market provides a unique place in the global economy. The highest GNP in the world means that the US spends more than any other country on current consumption and investment. An important factor that characterizes consumer demand in the US is the overall high level of income relative to other countries and a large segment of the middle class, focused on high standards of consumption. In the US, an average of 1.5 million new homes are started each year, more than 10 million new cars are sold, and a host of other durable goods are sold.

Sales Analysis us Pharmaceutical leadership fortified:

In 2004-2006 US pharmaceutical market not only habitually led, but also led active offensive actions strengthening positions in the global headlights market. Sales volume for the last 3 year grew from 174.5 to 197.8 billion dollars i.e. by $23.3 billion, or 13.3%. Moreover, the activity of the pharmaceutical market. The United States is provided by a constant increase in the growth rate of the market – from 4.6% in 2004 to 8.2% in 2006 Over the period 2004-2005 world growth rate pharmaceutical market was 7.6%, in the market In the United States, this figure was 4.6%.

If you look at these statistics, you will see that the US state is growing. The share of the American pharmaceutical market in the global average is 48%. This fact allows us to recognize American pharmaceutical market leader in international scale. Wherein, despite the fact that during the analyzed period there was a slight decrease in its share by 0.5% - this market remains the most large and growing.

I think the entire working contingent in the United States is characterized by a high educational level. The powerful scientific and technological potential of the country and the general high level of education and professional training of Americans serve as a strength factor for American corporations in their competitive struggle with rivals in the domestic and world markets.

The United States has consistently dominated world trade, the export of loan capital, direct and portfolio foreign investment. Today, this predominance is realized mainly in the scale of the economic potential and the dynamism of its development, scientific and technological progress, foreign investment and influence on the global financial market.

Timely recall of Viracept:

At the end of May 2007, on one of factories of the Swiss pharmaceutical company F.Hoffmann-La Roche, located in Spain, there was failure in the production of the Viracept drug. As a result, all series of Viracept throughout Europe, including in Russia were withdrawn.This drug, belonging to the group of protease inhibitors, is widely used to treat HIV infection. It is considered the safest drug, does not cause habituation, if necessary may be replaced by an alternative drug. Most often, Vira sept is prescribed to HIV-infected pregnant women and children. Viracept is supplied to Russia within the framework of the priority National project “Health”. At the June 14, 2007 "RIA Novosti" press conferences the head of the Russian representative office of the company F.Hoffmann-La Roche Milos Petrovic told about the reason for the recall and answered questions from journalists. According to him, the first reports about the appearance of an unusual "sulphurous" smell in the drug came from England.

We can see from this record that many difficult situations have occurred. But, despite this, the USA has retained its value. Thus, despite a number of problems, the United States still occupies a leading position in the world economy, producing the largest number of goods and services, leading in most absolute and relative economic indicators. The United States ranks first in the world in terms of industrial production. Today they account for about half of world grain exports. The service sector is developing dynamically and is taking an increasingly important place in the country's export activity. The leadership of the United States in the world economy is ensured mainly by their superiority over other countries in terms of the scale and wealth of the market, the degree of development of market structures, the level of scientific and technical potential, a powerful and extensive system of world economic relations with other countries through trade, investment and banking capital.

CHARACTERISTIC GENERIC AND BIOTECHNOLOGICAL MARKETS

When, I read these studies, I wanted to say, "America is truly a well-rounded nation." The US is a mature generics market, the largest in the world. The scope of this market increased in 2003-2006. With 16.5 to 21 billion dollars, or by 27.2%. The growth rate was 12.7–8.2%, respectively. US success in the world. The generics market is determined by the active development of this sector of the pharmaceutical industry in the country. The generics segment is dominated by drugs in the following therapeutic categories: drugs that affect the respiratory and central nervous systems, anticancer drugs and drugs, affecting the digestive system and metabolism. Cardiovascular drugs account for about 21% US generic market, antibiotics 14.4%, and slightly less analgesics 14%.

Link to the article: США - абсолютный лидер мирового фармрынка (cyberleninka.ru)

Authors of the article : Maria Chentsova

References: WORLD GENERIC MARKET IN 2003-2006: ANALYSIS AND DEVELOPMENT